ACS Chemical Neuroscience, published by the American Chemical Society, is a premier journal dedicated to exploring the complex interactions between chemistry and neuroscience. With its ISSN 1948-7193 and a distinguished impact factor that positions it within the top quartiles across multiple categories, including Q1 in Biochemistry, Q2 in Cell Biology, and Q1 in Physiology, this journal serves as an essential platform for researchers engaged in cutting-edge studies from 2010 to 2024. Positioned within the top 15% of its field in Cognitive Neuroscience according to Scopus rankings, ACS Chemical Neuroscience strives to foster interdisciplinary collaboration, publishing significant advancements that integrate chemical concepts with neurological processes. Despite its traditional publication model, the journal is committed to maintaining rigorous peer-review standards and providing valuable insights that drive innovations in therapeutics and understanding the biochemical underpinnings of brain function. Researchers, professionals, and students alike will find in this journal a vital resource for the latest findings and methodologies in the dynamic intersection of chemistry and neuroscience.

MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

JOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.

PROTEIN EXPRESSION AND PURIFICATION, published by Academic Press Inc. Elsevier Science, is a premier journal in the field of biotechnology. With its ISSN 1046-5928 and E-ISSN 1096-0279, the journal has been a vital source of knowledge since its inception in 1990 and continues to provide high-quality research up to 2025. Though categorized in the third quartile (Q3) for 2023 within its scope of biochemistry, genetics, and molecular biology, it serves as a valuable platform for scientists and researchers focusing on the latest advancements in protein expression methodologies and purification techniques. The journal enjoys a respectable Scopus rank of 177 out of 311 in its category, representing a 43rd percentile position that underscores its impact in the research community. While not an Open Access journal, it offers a wealth of insights that can significantly enhance one's understanding of protein biochemistry, making it a must-read for professionals and students alike engaged in this dynamic field.

International Journal of Peptide Research and Therapeutics, published by Springer, is a distinguished platform that bridges the gap between peptide research, therapeutic applications, and interdisciplinary sciences. With a focus on providing high-quality research, this journal covers a broad array of topics including analytical chemistry, biochemistry, drug discovery, and bioengineering, reflecting the essential role peptides play in modern medicine and biotechnology. The journal holds a respectable Q3 quartile ranking across its relevant fields as of 2023, underscoring its position as a noteworthy contributor to ongoing discussions in peptide science. Operating under an Open Access model, it aims to enhance the dissemination of knowledge and foster collaborative research efforts globally. Since its inception in 1996, the journal has evolved through various converged years to continue attracting submissions that push the boundaries of peptide research and its therapeutic potential. Researchers, professionals, and students are encouraged to engage with this journal to explore cutting-edge findings and contribute to the advancing field of peptide science.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

Protein Journal, published by Springer, stands as a significant academic resource in the fields of Analytical Chemistry, Biochemistry, Bioengineering, and Organic Chemistry. Since its inception in 1996, the journal has dedicated itself to the dissemination of high-quality research focused on protein chemistry and its biomedical applications. With an impressive impact reflected in its classification as a Q2 journal in Analytical Chemistry and Q3 in both Biochemistry and Bioengineering as of 2023, it provides an essential platform for researchers and practitioners to share their findings. The journal embraces the open-access model, enhancing accessibility to cutting-edge research. The Protein Journal is crucial for academicians, industry professionals, and students, catering to their need for rigorous scientific discourse and innovative discoveries in protein studies. With an established track record of converging over two decades of knowledge and research, it continues to influence and shape the advancements in this vital area of science.

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.